Compare CME & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CME | ELV |
|---|---|---|
| Founded | 1898 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5B | 78.9B |
| IPO Year | 2002 | N/A |
| Metric | CME | ELV |
|---|---|---|
| Price | $273.13 | $359.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | $285.33 | ★ $392.47 |
| AVG Volume (30 Days) | ★ 2.0M | 1.6M |
| Earning Date | 10-22-2025 | 01-22-2026 |
| Dividend Yield | ★ 3.95% | 1.90% |
| EPS Growth | ★ 8.52 | N/A |
| EPS | 10.32 | ★ 24.39 |
| Revenue | $6,385,200,000.00 | ★ $194,820,000,000.00 |
| Revenue This Year | $6.91 | $13.17 |
| Revenue Next Year | $4.98 | $3.66 |
| P/E Ratio | $26.51 | ★ $14.72 |
| Revenue Growth | 5.81 | ★ 11.96 |
| 52 Week Low | $224.62 | $273.71 |
| 52 Week High | $290.79 | $458.75 |
| Indicator | CME | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 69.23 |
| Support Level | $265.25 | $325.29 |
| Resistance Level | $273.34 | $336.45 |
| Average True Range (ATR) | 4.56 | 9.28 |
| MACD | -0.91 | 3.33 |
| Stochastic Oscillator | 46.52 | 91.45 |
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.